MENU
+Compare
IMAB
Stock ticker: NASDAQ
AS OF
Aug 11, 12:10 PM (EDT)
Price
$3.70
Change
+$0.29 (+8.50%)
Capitalization
278.46M

IMAB I-MAB Chart, History Price & Graph

a clinical stage biopharmaceutical company, which engages in developing and commercialization of differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders.

IMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMAB showed earnings on May 15, 2025. You can read more about the earnings report here.
View a ticker or compare two or three
IMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement

IMAB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IMAB has been loosely correlated with INDP. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if IMAB jumps, then INDP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMAB
1D Price
Change %
IMAB100%
-2.85%
INDP - IMAB
38%
Loosely correlated
+6.34%
RPRX - IMAB
31%
Poorly correlated
+1.54%
ALT - IMAB
30%
Poorly correlated
-1.99%
LGND - IMAB
27%
Poorly correlated
+2.56%
UNBX - IMAB
26%
Poorly correlated
-15.66%
More